ArticleESMO gastrointestinal oncology2025
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
D William et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.